Selecxine
PrivateLast Round
Series B
Mar 22, 2022
Total Funding Raised
$49.75M
Company Overview
Selecxine is a biopharmaceutical company that develops anti-cancer immunotherapeutics using its proprietary antibody discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Selecxine Comparables
Compare Selecxine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asher Biotherapeutics | 84% | |
| Synthekine | 82% | |
| Anaveon | 81% |
Selecxine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 22, 2022 | ||||
| Series A | May 7, 2020 |
Selecxine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hanwha Investment & Securities | Series A, Series B |
| iM Investment Partners | Series B |
| KCLAVIS Investment | Series B |
| UTC Investment | Series B |
| Medici Investment | Series B |
| K-Run Ventures | Series A |
| Stonebridge Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 29, 2022
$27M round led by Hanwha Investment & Securities and Medytox Venture Investment.
- May 7, 2020
$11M round with participation from Hanwha Investment & Securities.
Selecxine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Selecxine's valuation, stock price, and market status.
Is Selecxine a public or private company?
Selecxine is a private company.
What is the current stock price of Selecxine?
Selecxine is a private company with no public stock price. No recent secondary market data is available.
How much is Selecxine worth (valuation)?
Valuation information for Selecxine is not publicly available.
Can I buy Selecxine stock?
Selecxine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Selecxine's last funding round?
Selecxine's most recent funding round was Series B on March 29, 2022.
Who are the main investors in Selecxine?
Key investors in Selecxine include Hanwha Investment & Securities, Stonebridge Ventures, Medytox Venture Investment, SJ Investment Partners, STIC Ventures.
Will Selecxine IPO soon?
No public IPO plans have been announced for Selecxine.
How can I track Selecxine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Selecxine's secondary market activity and sign up for updates.